Company Filing History:
Years Active: 2003
Title: Innovations of Robert Alan Forbes
Introduction
Robert Alan Forbes is a notable inventor based in Clinton, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes that enhance the dissolution rates of medications. His work is essential for improving the efficacy of pharmaceutical products.
Latest Patents
Forbes holds a patent for a process titled "Process for preparing pharmaceutical bulk material having uniform dissolution." This invention provides a method for producing cefaclor crystalline bulk material that achieves a dissolution rate of ≥80% in water within 30 minutes. One of the key aspects of this process involves reducing the water content of cefaclor dihydrates to create a form with a water content of ≤2%. This lower water content cefaclor can then be rehydrated to a water content ranging from 3.0% to 6.5% without negatively impacting the dissolution rate. Additionally, an alternative method includes adding at least 0.05% of cefaclor related substances to prevent the conversion of the monohydrate to the dihydrate form.
Career Highlights
Forbes is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His work at Eli Lilly has allowed him to focus on enhancing drug formulations and improving patient outcomes through better medication delivery systems.
Collaborations
Throughout his career, Forbes has collaborated with several talented individuals, including Frank Brown, Jr. and Arlette Faye Kreager. These collaborations have contributed to the advancement of pharmaceutical technologies and the development of effective treatments.
Conclusion
Robert Alan Forbes is a distinguished inventor whose work in pharmaceutical processes has the potential to significantly impact medication efficacy. His innovative approach to enhancing dissolution rates demonstrates the importance of research and development in the pharmaceutical industry.